Natnov Bioscience Profile
Key Indicators
- Authorised Capital ₹ 6.00 M
as on 12-12-2024
- Paid Up Capital ₹ 5.05 M
as on 12-12-2024
- Company Age 3 Year, 18 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.55 Cr
as on 12-12-2024
- Revenue %
(FY 2023)
- Profit -1308.37%
(FY 2023)
- Ebitda -1278.57%
(FY 2023)
- Net Worth 6391.01%
(FY 2023)
- Total Assets 288054.10%
(FY 2023)
About Natnov Bioscience
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 6.00 M and a paid-up capital of Rs 5.05 M.
The company currently has active open charges totaling ₹1.55 Cr.
Siddhartha Pati and Debabrata Panda serve as directors at the Company.
- CIN/LLPIN
U24290OR2021PTC038366
- Company No.
038366
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
06 Dec 2021
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Cuttack
Industry
Company Details
- Location
Baleswar, Odisha, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Natnov Bioscience Private Limited offer?
Natnov Bioscience Private Limited offers a wide range of products and services, including Pharma Ingredients & Raw Materials, Anti Infective API, Flavours & Aromatics, Food Stabilizer.
Who are the key members and board of directors at Natnov Bioscience?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Siddhartha Pati  | Managing Director | 06-Dec-2021 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Debabrata Panda | Director | 06-Dec-2021 | Current |
Financial Performance of Natnov Bioscience.
Natnov Bioscience Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 1308.37% decrease in profit. The company's net worth Soared by an impressive increase of 6391.01%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Natnov Bioscience?
Unlock access to Natnov Bioscience's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 04 May 2023 | ₹1.55 Cr | Open |
How Many Employees Work at Natnov Bioscience?
Unlock and access historical data on people associated with Natnov Bioscience, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Natnov Bioscience, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Natnov Bioscience's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
